Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Archives of Neurology|July 18, 2012
Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer diseaseHolly D Soares, William Z Potter, Eve Pickering, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 11, 2010
Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjectsJohn Q Trojanowski, Hugo Vandeerstichele, Magdalena Korecka, et al.
Science Translational Medicine|November 5, 2025
Beyond Alzheimer's disease-translating biomarker insights across CNS diseasesLinda S Brady, Simin Mahinrad, Rebecca M Edelmayer, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 14, 2020
Proof of mechanism and target engagement of glutamatergic drugs for the treatment of schizophrenia: RCTs of pomaglumetad and TS-134 on ketamine-induced psychotic symptoms and pharmacoBOLD in healthy volunteersJoshua T Kantrowitz, Jack Grinband, Donald C Goff, et al.
Nature Medicine|April 2, 2020
A randomized proof-of-mechanism trial applying the 'fast-fail' approach to evaluating κ-opioid antagonism as a treatment for anhedoniaAndrew D Krystal, Diego A Pizzagalli, Moria Smoski, et al.
Neuroimage. Clinical|March 11, 2019
A multicenter study of ketamine effects on functional connectivity: Large scale network relationships, hubs and symptom mechanismsLeah M Fleming, Daniel C Javitt, Cameron S Carter, et al.
The Journal of Clinical Psychiatry|February 5, 2009
The history and current state of antidepressant clinical trial design: a call to action for proof-of-concept studiesAlan J Gelenberg, Michael E Thase, Roger E Meyer, et al.
JAMA Psychiatry|November 24, 2017
Utility of Imaging-Based Biomarkers for Glutamate-Targeted Drug Development in Psychotic Disorders: A Randomized Clinical TrialDaniel C Javitt, Cameron S Carter, John H Krystal, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 12, 2024
Head-to-head comparison of leading blood tests for Alzheimer's disease pathologySuzanne E Schindler, Kellen K Petersen, Benjamin Saef, et al.
Medrxiv : the Preprint Server for Health Sciences|July 1, 2024
Head-to-head comparison of leading blood tests for Alzheimer's disease pathologySuzanne E Schindler, Kellen K Petersen, Benjamin Saef, et al.
Pageof 7